ENDOLOGIX INC /DE/ Restructuring Costs
ENDOLOGIX INC /DE/ reported Restructuring Costs of $16.70 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-27.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2020-05-27
- ENDOLOGIX INC /DE/ restructuring costs for the quarter ending 2020-03-31 was $16.70M, a 2.45% increase year-over-year.
- ENDOLOGIX INC /DE/ restructuring costs for the quarter ending 2019-09-30 was $400.00K, a 86.67% decline year-over-year.
- ENDOLOGIX INC /DE/ restructuring costs for the quarter ending 2019-06-30 was $0.00.
- ENDOLOGIX INC /DE/ restructuring costs for the quarter ending 2019-03-31 was $16.30M.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 27 month | Restructuring Costs 33 month | Restructuring Costs 39 month | Restructuring Costs 45 month | Restructuring Costs 51 month |
|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | $16.70M 10-Q · filed 2020-05-27 | $16.70M 10-Q · filed 2020-05-27 | ||||||
| 2019-09-30 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $400.00K derived: sum of 2 quarters · filed 2019-11-07 | $16.70M 10-Q · filed 2019-11-07 | $16.30M 10-Q · filed 2019-11-07 | ||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $16.30M 10-Q · filed 2019-08-09 | ||||||
| 2019-03-31 | $16.30M 10-Q · filed 2019-05-08 | $16.30M 10-Q · filed 2019-08-09 | ||||||
| 2018-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $15.80M 10-Q · filed 2018-11-08 | $15.70M 10-Q · filed 2018-11-08 | |||||
| 2018-06-30 | $12.80M 10-Q · filed 2018-08-09 | |||||||
| 2018-03-31 | $12.80M 10-Q · filed 2018-05-09 |